In comparison to influenza-infected subjects, the COVID-19 subjects in the validation cohort also exhibited many of the same patterns observed within the primary COVID-19 cohort with the single exception of MIP-1α (P = 0.14), which may have differed due to variations in the assay’s lower limits of detection. The gene discussed is CCL3; the disease is influenza.